Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 113251-113300 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT02714634
Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide
PHASE4
Recruiting
286 participants
Started: Mar 30, 2016 · Completed: Mar 31, 2029
2 conditions
1 sponsor
1 location
NCT02726763
Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training
NA
Active, not recruiting
18 participants
Started: Mar 30, 2016 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT03792659
The EXPLORE MG Registry for Myasthenia Gravis
N/A
Recruiting
800 participants
Started: Mar 30, 2016 · Completed: Oct 30, 2026
1 condition
1 sponsor
1 location
NCT03023202
UWCCC Molecular Tumor Board Registry
N/A
Recruiting
10,000 participants
Started: Mar 30, 2016 · Completed: Mar 31, 2027
2 conditions
2 sponsors
1 location
NCT02914158
Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women
PHASE3
Recruiting
680 participants
Started: Mar 30, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
25 locations
NCT03152630
Research on the Early and Prognosis Diagnosis of Vascular Dementia
N/A
Recruiting
600 participants
Started: Mar 30, 2016 · Completed: Jan 31, 2036
1 condition
1 sponsor
1 location
NCT05698940
Subjective and Objective Outcome of Septoplasty With or Without Infundibulotomy
NA
Recruiting
35 participants
Started: Mar 29, 2016 · Completed: Dec 31, 2024
3 conditions
1 sponsor
1 location
NCT02451982
Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas
PHASE2
Active, not recruiting
76 participants
Started: Mar 28, 2016 · Completed: May 31, 2026
1 condition
3 sponsors
1 location
NCT03718923
FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.
N/A
Recruiting
50 participants
Started: Mar 28, 2016 · Completed: Apr 30, 2026
3 conditions
4 sponsors
1 location
NCT02446600
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE3
Active, not recruiting
579 participants
Started: Mar 28, 2016 · Completed: Aug 23, 2026
13 conditions
3 sponsors
356 locations
NCT04565704
Optical Imaging of Gastrointestinal Biopsy Samples and Their Correlation With Histology
NA
Enrolling by invitation
200 participants
Started: Mar 25, 2016 · Completed: Dec 31, 2028
2 conditions
1 sponsor
1 location
NCT02688712
ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer
PHASE2
Active, not recruiting
50 participants
Started: Mar 24, 2016 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT02617966
Rod and Cone Mediated Function in Retinal Disease
N/A
Recruiting
500 participants
Started: Mar 24, 2016 · Completed: Dec 30, 2029
3 conditions
1 sponsor
1 location
NCT05456334
New Treatments for Actinic Keratoses of the Scalp
NA
Active, not recruiting
120 participants
Started: Mar 24, 2016 · Completed: Dec 31, 2024
2 conditions
1 sponsor
0 locations
NCT02900833
Impact of Neutrophil Activation in Acute Ischemic Stroke Patients Treated With Endovascular Therapy
N/A
Active, not recruiting
440 participants
Started: Mar 24, 2016 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT07154537
Pneumococcal Conjugated Vaccine 13 (PCV13) for Patients With Multiple Myeloma (MM)
PHASE4
Active, not recruiting
101 participants
Started: Mar 23, 2016 · Completed: Jul 31, 2027
1 condition
2 sponsors
1 location
NCT02638090
Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)
PHASE1/PHASE2
Active, not recruiting
120 participants
Started: Mar 22, 2016 · Completed: Jan 21, 2026
2 conditions
2 sponsors
1 location
NCT02632409
An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
PHASE3
Active, not recruiting
709 participants
Started: Mar 22, 2016 · Completed: May 27, 2027
1 condition
2 sponsors
188 locations
NCT02867033
National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)
NA
Active, not recruiting
628 participants
Started: Mar 22, 2016 · Completed: Nov 30, 2031
1 condition
4 sponsors
38 locations
NCT02526368
Pilot Study of (MR) Imaging with Pyruvate (13C) to Detect High Grade Prostate Cancer
EARLY_PHASE1
Recruiting
80 participants
Started: Mar 22, 2016 · Completed: Dec 31, 2026
2 conditions
4 sponsors
1 location
NCT02692885
Molecular, Cellular, and Genetic Characterization of Human Adipose Tissue and Its Role in Metabolism
N/A
Recruiting
300 participants
Started: Mar 22, 2016 · Completed: Oct 31, 2025
3 conditions
1 sponsor
1 location
NCT02644369
Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors
PHASE2
Active, not recruiting
100 participants
Started: Mar 21, 2016 · Completed: Dec 31, 2026
5 conditions
2 sponsors
1 location
NCT04439188
Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Loss of Expression (MATCH-Subprotocol P)
PHASE2
Active, not recruiting
35 participants
Started: Mar 21, 2016 · Completed: Dec 31, 2026
6 conditions
1 sponsor
1 location
NCT03309384
Intraoperative Monitoring to Predict Postoperative Complications After Thyroidectomy
N/A
Recruiting
1,000 participants
Started: Mar 20, 2016 · Completed: Mar 20, 2026
4 conditions
1 sponsor
1 location
NCT05624905
Prospective Pecutaneous Coronary Intervention Registry
N/A
Recruiting
15,000 participants
Started: Mar 20, 2016 · Completed: Dec 31, 2030
2 conditions
1 sponsor
1 location
NCT02629809
Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia
PHASE2
Active, not recruiting
81 participants
Started: Mar 18, 2016 · Completed: Mar 31, 2026
2 conditions
1 sponsor
1 location
NCT02734004
A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
PHASE1/PHASE2
Active, not recruiting
264 participants
Started: Mar 17, 2016 · Completed: Sep 17, 2025
4 conditions
2 sponsors
47 locations
NCT02742493
RCT for the Effectiveness of 3 Orthodontic Retention Schemes on Post-treatment Stability and Gingival Recession
NA
Active, not recruiting
60 participants
Started: Mar 16, 2016 · Completed: Nov 1, 2025
2 conditions
1 sponsor
1 location
NCT04049890
Development and Validation of Family Adjustment Inventory
N/A
Recruiting
900 participants
Started: Mar 15, 2016 · Completed: Sep 14, 2026
1 condition
2 sponsors
1 location
NCT02693535
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
PHASE2
Recruiting
4,200 participants
Started: Mar 14, 2016 · Completed: Dec 31, 2028
3 conditions
11 sponsors
160 locations
NCT02604563
Aging, Geriatric Syndromes and Clonal Hematopoiesis
N/A
Recruiting
2,000 participants
Started: Mar 10, 2016 · Completed: Apr 30, 2030
4 conditions
2 sponsors
1 location
NCT02500849
Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients
PHASE1
Active, not recruiting
12 participants
Started: Mar 10, 2016 · Completed: Aug 24, 2026
1 condition
3 sponsors
5 locations
NCT03850366
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
PHASE2
Recruiting
15 participants
Started: Mar 8, 2016 · Completed: Jan 1, 2027
1 condition
1 sponsor
1 location
NCT02653105
Women at Risk of Breast Cancer and OLFM4
NA
Active, not recruiting
150 participants
Started: Mar 8, 2016 · Completed: Mar 31, 2026
1 condition
1 sponsor
4 locations
NCT02535312
Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin
PHASE1/PHASE2
Active, not recruiting
30 participants
Started: Mar 8, 2016 · Completed: Oct 17, 2025
7 conditions
1 sponsor
14 locations
NCT02717611
A Study of ACP-196 (Acalabrutinib) in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy
PHASE2
Active, not recruiting
60 participants
Started: Mar 8, 2016 · Completed: Sep 6, 2026
1 condition
1 sponsor
23 locations
NCT02715284
Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors
PHASE1
Recruiting
740 participants
Started: Mar 7, 2016 · Completed: Oct 27, 2027
1 condition
1 sponsor
130 locations
NCT02670707
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
PHASE3
Recruiting
124 participants
Started: Mar 7, 2016 · Completed: Jan 31, 2029
1 condition
1 sponsor
11 locations
NCT02192359
Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PHASE1
Active, not recruiting
18 participants
Started: Mar 7, 2016 · Completed: Oct 15, 2025
7 conditions
2 sponsors
1 location
NCT02686125
Vercise™ DBS Dystonia Prospective Study
N/A
Recruiting
300 participants
Started: Mar 7, 2016 · Completed: Dec 31, 2030
1 condition
1 sponsor
36 locations
NCT03705546
The Impact of Physical Activity on the Postoperative Symptoms, Complications, and Quality of Life Among Lung Cancer
N/A
Active, not recruiting
1,050 participants
Started: Mar 4, 2016 · Completed: Mar 3, 2026
1 condition
1 sponsor
1 location
NCT02994719
Gait Analysis in Neurological Disease
N/A
Recruiting
120 participants
Started: Mar 1, 2016 · Completed: Jun 20, 2026
8 conditions
1 sponsor
1 location
NCT02716012
First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer
PHASE1
Active, not recruiting
75 participants
Started: Mar 1, 2016 · Completed: Jul 31, 2025
2 conditions
1 sponsor
11 locations
NCT04556188
The Clinical Influence of Developing a Sustainable Cardiac Surgery Service to Reduce the Burden of Rheumatic Heart Disease in Sub-Saharan Africa
N/A
Recruiting
200 participants
Started: Mar 1, 2016 · Completed: Jun 30, 2026
2 conditions
3 sponsors
4 locations
NCT02639650
Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor
PHASE3
Recruiting
214 participants
Started: Mar 1, 2016 · Completed: Mar 1, 2026
1 condition
4 sponsors
1 location
NCT03330587
Living Alone in Old Age With Cognitive Impairment
N/A
Active, not recruiting
60 participants
Started: Mar 1, 2016 · Completed: May 31, 2025
3 conditions
1 sponsor
1 location
NCT03707379
The Effect of Share Care Model in the Improvement of Diabetes Management
N/A
Recruiting
3,500 participants
Started: Mar 1, 2016 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT03019471
Non Invasive Cancer Test (NICT): a Proof of Principle Study.
N/A
Recruiting
40 participants
Started: Mar 1, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03749343
International T1 Multicenter Outcome Study
N/A
Active, not recruiting
8,000 participants
Started: Mar 1, 2016 · Completed: Feb 28, 2030
5 conditions
3 sponsors
3 locations
NCT02747888
Hereditary Risk Factors for Thyroid Cancer
NA
Recruiting
250 participants
Started: Mar 1, 2016 · Completed: Mar 1, 2029
1 condition
1 sponsor
1 location
Previous
1
More pages
2263
2264
2265
2266
2267
2268
2269
More pages
2369
Next